Literature DB >> 33580322

Sex differences in ventromedial hypothalamic nucleus glucoregulatory transmitter biomarker protein during recurring insulin-induced hypoglycemia.

K P Briski1, Md Haider Ali2, Prabhat R Napit2, A S M H Mahmood2, A R Alhamyani2, A A Alshamrani2, Mostafa M H Ibrahim2.   

Abstract

Recurring insulin-induced hypoglycemia (RIIH) in males correlates with maladaptive glucose counter-regulatory collapse and acclimated expression of ventromedial hypothalamic nucleus (VMN) nitric oxide (NO) and γ-aminobutyric acid (GABA) metabolic transmitter biomarkers, e.g., neuronal nitric oxide synthase (nNOS) and glutamate decarboxylase65/67 (GAD). Hindbrain noradrenergic neurons innervate the VMN, where norepinephrine regulates nNOS and GAD expression. Current research investigated the hypothesis that antecedent hypoglycemia (AH) exposure causes sex-dimorphic habituation of VMN glucoregulatory biomarker proteins between and/or during serial hypoglycemic bouts, and that hindbrain catecholaminergic (CA) signaling may control sex-specific adaptation of one or more of these proteins. Data show that upon recovery from AH, females exhibit CA-mediated reductions in baseline VMN nNOS, GAD, steroidogenic factor-1 (SF-1), and brain-derived neurotrophic factor (BNDF) expression compared to euglycemic profiles. In males, however, AH caused 6-OHDA-insensitive suppression of only basal SF-1 levels in the VMN. VMN transmitter protein acclimation to RIIH was sex-contingent, as differential nNOS, GAD, SF-1, and BDNF responses to a single vs final bout of hypoglycemia occur in males, whereas females show acclimated reactivity of GAD and SF-1 only to renewed hypoglycemia. CA-mediated and -independent habituation of distinctive VMN protein profiles occurred in each sex. Further research is necessary to evaluate, in each sex, effects of altered baseline VMN metabolic neurotransmitter signals on glucose homeostasis as well as non-metabolic functions under the control of those neurochemicals. It would also be insightful to learn if and how sex-contingent habituation of VMN transmitter responses to hypoglycemia contribute to sex-dimorphic patterns of glucose counter-regulation during RIIH.

Entities:  

Keywords:  6-Hydroxydopamine; Glutamate decarboxylase; Nitric oxide synthase; Recurrent insulin-induced hypoglycemia; Sex differences; Ventromedial hypothalamic nucleus

Mesh:

Substances:

Year:  2021        PMID: 33580322      PMCID: PMC8038965          DOI: 10.1007/s00429-021-02225-8

Source DB:  PubMed          Journal:  Brain Struct Funct        ISSN: 1863-2653            Impact factor:   3.270


  3 in total

1.  Sex-dimorphic estrogen receptor regulation of ventromedial hypothalamic nucleus glucoregulatory neuron adrenergic receptor expression in hypoglycemic male and female rats.

Authors:  M Main Uddin; A S M Hasan Mahmood; Mostafa M H Ibrahim; Karen P Briski
Journal:  Brain Res       Date:  2019-06-29       Impact factor: 3.252

2.  Sex-dimorphic Rostro-caudal Patterns of 5'-AMP-activated Protein Kinase Activation and Glucoregulatory Transmitter Marker Protein Expression in the Ventrolateral Ventromedial Hypothalamic Nucleus (VMNvl) in Hypoglycemic Male and Female Rats: Impact of Estradiol.

Authors:  Ayed A Alshamrani; Khaggeswar Bheemanapally; Abdulrahman Alhamyani; Md Haider Ali; Prabhat R Napit; Md Main Uddin; A S M Hasan Mahmood; Mostafa M H Ibrahim; Karen P Briski
Journal:  J Mol Neurosci       Date:  2020-11-24       Impact factor: 3.444

Review 3.  Hypothalamic glucose sensing: making ends meet.

Authors:  Vanessa H Routh; Lihong Hao; Ammy M Santiago; Zhenyu Sheng; Chunxue Zhou
Journal:  Front Syst Neurosci       Date:  2014-12-10
  3 in total
  1 in total

1.  Hindbrain lactate regulation of hypoglycemia-associated patterns of catecholamine and metabolic-sensory biomarker gene expression in A2 noradrenergic neurons innervating the male versus female ventromedial hypothalamic nucleus.

Authors:  Md Haider Ali; Ayed A Alshamrani; Karen P Briski
Journal:  J Chem Neuroanat       Date:  2022-04-25       Impact factor: 3.097

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.